Back to Search
STEVEN HARRISON, M.D.
M.D.
Retina Specialist (Ophthalmology) Physician
NPI: 1821023755IndividualAccepts Medicare
Specialties, Licenses & Credentials
Ophthalmology Physician
Ophthalmology
Code: 207W00000X
G63736(CA)
Retina Specialist (Ophthalmology) PhysicianPrimary
Ophthalmology — Retina Specialist
Code: 207WX0107X
G63736(CA)
CMS Specialties
PrimaryOPHTHALMOLOGY
Education
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
Class of 1987
Clinical Trials (4)
4
Linked Trials
0
Recruiting
0
With Results
Study for the Treatment of Significant Steatosis With Xenical Followed by Treatment of Hepatitis C With Pegasys/Copegus
NCT00207311COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Does Induction PEG-Intron in Combination With Rebetol Enhance the Sustained Response Rates in Patients With CHC
NCT00207363COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Infergen, Ribavirin & Avandia in Previous Relapsers or Nonresponders to Pegylated Interferon and Ribavirin
NCT00207402COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Efficacy of Actos Lipitor Pegasys & Ribavirin in CHC GT 1 Patients Who Relapsed or Nonresponded to Peg/Riba
NCT00926614COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Research & Publications (20)
Induction pegylated interferon alfa-2b in combination with ribavirin in patients with genotypes 1 and 4 chronic hepatitis C: a prospective, randomized, multicenter, open-label study.
PMID 19747986·Clin Gastroenterol Hepatol·2010
4-observational
A functional role for the dopamine D3 receptor in the induction and expression of behavioural sensitization to ethanol in mice.
PMID 19662386·Psychopharmacology (Berl)·2009
7-preclinical
Load affects human odometry for travelled distance but not straight-line distance.
PMID 19583996·Neurosci Lett·2009
8-other
Orlistat for overweight subjects with nonalcoholic steatohepatitis: A randomized, prospective trial.
PMID 19053049·Hepatology·2009
2-rct
Differential susceptibility to ethanol and amphetamine sensitization in dopamine D3 receptor-deficient mice.
PMID 19096829·Psychopharmacology (Berl)·2009
7-preclinical
Level of physical activity and characteristics associated with change following breast cancer diagnosis and treatment.
PMID 19117320·Psychooncology·2009
8-other
Insulin resistance among patients with chronic hepatitis C: etiology and impact on treatment.
PMID 18585970·Clin Gastroenterol Hepatol·2008
6-review
Within-texture collinearity improves human texture segmentation.
PMID 18611407·Vision Res·2008
8-other
Sun exposure and the incidence of melanocytic nevi in young Australian children.
PMID 18768500·Cancer Epidemiol Biomarkers Prev·2008
8-other
Mapping the minimal regions within the ORF73 protein required for herpesvirus saimiri episomal persistence.
PMID 18931082·J Gen Virol·2008
7-preclinical
Toward a better understanding of the regional causes of local community richness.
PMID 18513314·Ecol Lett·2008
6-review
Generation and expression of a minimal hybrid Ig-receptor formed between single domains from proteins L and G.
PMID 18158250·Protein Expr Purif·2008
8-other
Abnormal liver tests and fatty liver on ultrasound.
PMID 18166475·Clin Gastroenterol Hepatol·2008
8-other
Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease.
PMID 18390575·Gut·2008
4-observational
Is the FIBROSpect II index effective for determining the stage of fibrosis in patients with chronic hepatitis C?
PMID 18087299·Nat Clin Pract Gastroenterol Hepatol·2008
8-other
Enumeration of blood dendritic cells in patients with multiple myeloma at presentation and through therapy.
PMID 19052974·Leuk Lymphoma·2008
8-other
Montelukast inhibits inflammatory responses in small airways of the Guinea-pig.
PMID 17905619·Pulm Pharmacol Ther·2008
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1299 NEWELL HILL PL, SUITE 103
WALNUT CREEK, CA 94596 - Phone
- (925) 947-0505
Quick Facts
- NPI
- 1821023755
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 39
- Clinical Trials
- 4
- Publications
- 20
Are you this provider?
Claim Your Profile